- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
NexGen Releases New Drill Results, Dundee Urges Patience
NexGen Energy has released its latest set of assay results. However, a report from Dundee Capital Markets cautions investors to remain patient.
NexGen Energy (TSXV:NXE) released its latest set of assay results from the Arrow Zone on its Rook I property, but received little adulation from analysts.
The results, taken from 16 drill holes from a summer drill program, rangeĀ from 2.34 percent U3O8 over 26.5 meters and 1.05 percent U3O8 over 20.5 meters in two vertical holes, and 0.41 percent U3O8 over 83 meters and 0.45 percent U308 over 74.65 meters in two of 14 angled holes.
However, a report authored by David Talbot with Dundee Capital Markets states that ā(it)Ā is likely the assaysĀ from one of the vertical holes will disappoint investors.ā
That said, the analyst does go on to say that the results will likely help NexGen plan its next drill holes to continue high-grade results and narrow what depths should be focused on. Furthermore, Dundee still gives the company a ābuyā rating, though it cautions investors to remain patient.
āWe do like Arrow and believe there will be plenty of furtherĀ success once management and its technical team determine the controls onĀ mineralization. But until then, investors may have to be patient, and endureĀ periods of high grade intercepts and lower grade misses,ā writes Talbot.
At time of reporting, NexGenās share price had fallen 2.63 percent to settle at $0.37 per share.
Ā
Securities Disclosure: I, Nick Wells, hold no direct investment in any of the companies mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to theĀ cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Ā